Stay updated on IGF-1/IGFBP3 for ROP Prevention Clinical Trial
Sign up to get notified when there's something new on the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page.

Latest updates to the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedA centralized Locations section was added, listing study sites by state (Alabama, California, Georgia, Mississippi, North Carolina, Oklahoma, West Virginia, Wisconsin). The previously separate per-state location subsections were removed.SummaryDifference0.8%

- Check57 days agoChange DetectedPublications section edits clarify that items may be entered voluntarily and may not always relate to the study results, and that some publications are auto-filled from PubMed. The revision tag was updated to v3.3.2.SummaryDifference0.1%

- Check64 days agoChange DetectedThe government funding/status notice banner was removed. This change does not affect the displayed study details or how to navigate the page.SummaryDifference0.3%

- Check79 days agoChange DetectedMinor UI/layout adjustments were observed on the Study Details page, with core content such as eligibility criteria, locations, and outcomes remaining unchanged.SummaryDifference0.3%

- Check108 days agoChange DetectedAdditions introduce a new topic and an updated revision (v3.2.0) along with a government-status notice; the old version (v3.1.0) was removed.SummaryDifference3%

Stay in the know with updates to IGF-1/IGFBP3 for ROP Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page.